Contribution: Industrial Research Assistance Program – Contributions to Firms
Celestra Health Systems Corporation
$382,000.00
Germany-ZIM - MS Patient Gait Monitoring - AI Classifiers and Real World Gait Sensors for MS Patient Monitoring
FY 2024-25 · 2024-05-01
Summary
“As part of the international consortium project “[MS Patient Gait Monitoring]”, this project will focus on AI-based Digital Biomarker for the Objective Measurement of Gait in Multiple Sclerosis (MS) Patients.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Ottawa|Ottawa, Ontario, Canada
Recipient Type
For-profit organization
Business Number
716041942
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2024-05-01 | 2024-25 | $312,000.00 |
| 2 | 2024-05-01 | 2024-25 | $382,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The total amended value is 70,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La valeur totale des modifications est de 70 000 dollars.
Agreement End Date
2026-06-30
Agreement Number
1019330
Agreement Start Date
2024-05-01
Agreement Title
Germany-ZIM - MS Patient Gait Monitoring - AI Classifiers and Real World Gait Sensors for MS Patient Monitoring
Agreement Title (French)
Allemagne — ZIM — Suivi de la démarche des patients atteints de SEP — Classificateurs d’IA et capteurs de démarche en situation réelle pour le suivi des patients atteints de SEP
Agreement Type
Contribution
Agreement Value
$382,000.00
Amendment Date
2025-12-16
Amendment Number
2
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
“As part of the international consortium project “[MS Patient Gait Monitoring]”, this project will focus on AI-based Digital Biomarker for the Objective Measurement of Gait in Multiple Sclerosis (MS) Patients.
Description (French)
Dans le cadre du projet de consortium international [MS Patient Gait Monitoring]», ce projet se concentrera sur les biomarqueurs numériques basés sur l’IA pour la mesure objective de la démarche chez les patients atteints de sclérose en plaques (SEP).
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Kanata--Carleton
Federal Riding (French)
Kanata--Carleton
Federal Riding Number
35041
NAICS Code
33911
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
716041942
Recipient City
Ottawa|Ottawa
Recipient Country
CA
Recipient Legal Name
Celestra Health Systems Corporation
Recipient Operating Name
Celestra Health Systems
Recipient Postal Code
K2K 0G7
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2024-2025-Q1-1019330
